Erik Lundström
Adjunct Professor at Department of Medical Sciences; Neurology
- E-mail:
- erik.lundstrom@uu.se
- Visiting address:
- Akademiska sjukhuset
- Postal address:
- Akademiska sjukhuset, ing 85 plan 2
751 85 UPPSALA
Download contact information for Erik Lundström at Department of Medical Sciences; Neurology
- ORCID:
- 0000-0002-5313-9052
Short presentation
Vision for science
Stroke research that matters.
Vision as a leader
Inject people with passion.
I was the Chief Investigator of the EFFECTS (Efficacy of Fluoxetine – a randomised controlled trial in stroke) trial, published in The Lancet Neurology. You're welcome to connect with me on TWITTER and Facebook.
Keywords
- stroke
- akut neurologi
- neurology
- fluoxetine
- plasticity
- randomised controlled trial
- rct
Biography
Current position
- Consultant in Neurology at Uppsala University Hospital and clinical lead for the stroke unit. Ongoing (since April 2018).
- Senior lecturer of Neurology at Department of Neuroscience, Uppsala University. Ongoing (since July 2018).
- Chief Investigator of EFFECTS, the largest randomised controlled stroke study in Sweden. Although we reported the main results in Lancet Neurology Aug 2020, we continue to publish important results.
- EFFECTS was an academic-initiated, investigated led multicentre, parallel-group, randomised, placebo-controlled trial of fluoxetine for stroke recovery.
- We investigated whether routine administration of fluoxetine 20mg once daily in the 6 months after an acute stroke improves the patient’s functional outcome.
- EFFECTS was supported by the Swedish Research Council (Vetenskapsrådet), the Swedish Brain Foundation,(Hjärnfonden), the Swedish Heart-Lung Foundation (Hjärt- Lungfonden), the Swedish Society of Medicine (Svenska Läkaresällskapet), the Swedish Stroke Association (Stroke Riksförbundet), King Gustav V and Queen Victorias Foundation of Freemasons, Karolinska Institutet, and Uppsala University. All funders are non-commercial. None of the funders have any influence on the planning, conduct or interpretation of the study.
Medical degrees
- Associate Professor of Neurology, Uppsala University. 2022.
- Associate Professor of Neurology at Karolinska Institutet. 2017.
- Dissertation at Uppsala University, Sweden, Inst f Neuroscience, Neurology and rehabilitation medicine. Spasticity after first-ever stroke. 2009.
- Medical Degree at Uppsala University. 1993.
Supervision for PhD students
- Co-supervisor of Svante Wallmark, at Uppsala University, Department of Neuroscience, Neurosurgery. Dr Wallmarks thesis studied the effects of subarachnoid haemorrhage, including cognitive impairment, and defended his thesis Life after subarachnoid haemorrhage 17/01/2017.
- Supervisor of Ann-Sofie Rudberg and Eva Isaksson, both at Karolinska Institutet.
- Dr Rudberg's projects will investigate long-term survival, health-related quality of life and cost aspects associated with stroke treatment, and will be based on two clinical stroke studies: IST-3 and EFFECTS. Ongoing.
- Eva Isaksson's thesis aims to describe factors that contribute to successful recruitment in a randomised controlled trial. Ongoing.
- Co-supervision for Melinda Berg Roaldsen, PhD student at UiT The Arctic University of Norway (ongoing). Roaldsen's research focuses on thrombolytic treatment of acute ischaemic stroke with a special emphasis on wake-up stroke. She is currently the international Trial Manager of the randomised-controlled trial TWIST (Tenecteplase in Wake-up Ischaemic Stroke Trial). Ongoing,
Supervision of students
- 14 students at Uppsala University, Medicine Programme, student thesis, 9 x 30 credits, 5 x 7,5 credits
- 1 student at Karolinska Institutet, Medicine Programme, 30 credits
- 1 student at Gothenburg University, Pharmacy Programme, 30 credits
Teaching
- Extensive teaching (> 400 h) for medical students, physiotherapists and nurses at Uppsala University. Also taught at the physiotherapist-, speech therapy- and at biomedical analysts-programme, Uppsala University.
- Some teaching at the medical programme, Karolinska Institutet.
Clinical experience since 2005
- Consultant Neurology and Medically responsible doctor for the stroke unit at Karolinska University Hospital, Solna. Between December 2012 and Mars mars 2018.
- Consultant Neurology, Uppsala University Hospital. 2012.
- Specialist in neurology Uppsala University Hospital and specialist examination in Neurology 2005.
Research
CURRENT PROJECT
TICH-3 Cog
Every year, 1.7 million, experience a spontaneous brain haemorrhage, and out of those who manage to survive, one-third of them develop cognitive issues. In the case of Sweden, there is a prevalence of 2,700 cases of brain haemorrhage annually. Presently, there is no emergency medical intervention available except for the reduction of blood pressure. Despite the patients' emphasis on cognition as the most crucial research area and the European Stroke Organization's identification of significant gaps in knowledge, there is a paucity of randomized controlled studies investigating the possibility of mitigating cognitive impairment.
TICH-3 Cog in an acronym for Tranexamic acid for Hyperacute Spontaneous Intracerebral Haemorrhage Cognition.
The goal TICH-3 Cog trial is to investigate whether tranexamic acid could reduce cognitive impairment when given within 4.5 hours after intracerebral haemorrhage? The hypothesis is that tranexamic acid reduces the size of the haemorrhage and thereby reduces secondary brain damage. The primary outcome measure is cognition at 1 year as measured by the Montreal Cognitive Assessment scale.
Half of the patients will receive an intravenous infusion of tranexamic acid and the other half a placebo. Treatment begins within 4.5 hours of becoming ill.
TICH-3 Cog is a Swedish sub-study embedded in the international TICH-3 trial
TICH-3 Cog is embedded in the Tranexamic acid for Intracerebral Haemorrhage (TICH-3) trial, a pragmatic phase III prospective randomized placebo-controlled study that aims to include 5,500 individuals from around the world.
The research plan for TICH-3 Cog is written in collaboration with the principal investigator for TICH-3, Prof Nikola Sprigg, Nottingham, UK. The primary outcome measure for TICH-3 is death within 7 days.
Details of the TICH-3 trial can be found here.
PREVIOUS AND ONGOING WORK
The EFFECTS study
The purpose of EFFECTS was to find a new treatment for stroke recovery. We tested whether an established drug against depression (Fluoxetine) could improve recovery and quality of life after stroke.
The primary outcome was neutral. You can read about the results in the Lancet Neurology here.
The project’s originality and novelty
- We were studying a new mechanism for stroke, selective serotonin re-uptake inhibitors (SSRI), for stroke recovery. We wanted to test whether routine administration of Fluoxetine (20 mg once daily) in the 6 months after an acute stroke improves the patient’s functional outcome.
- An academic-initiated, investigator-led, randomised controlled study (RCT).
- We included 1,500 patients in Sweden, making EFFECTS the largest RCT study of stroke in Sweden.
- A collaboration with FOCUS (published in Lancet) and AFFINITY (published in the Lancet Neurology) two other international, investigator-led studies, with the same inclusion and exclusion criteria. A meta-analysis of individual patient data is planned.
- It has a pragmatic design, that is we investigate if the interventions work in normal practice, with fewer selected patients and a flexible intervention applied as it would be in normal practice, and finally, outcomes that are relevant to patients and society.
- The study includes both ischemic and haemorrhagic stroke.

Publications
Recent publications
-
Part of Upsala Journal of Medical Sciences, 2025
- DOI for Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trial
- Download full text (pdf) of Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trial
-
Part of International Journal of Stroke, p. 540-549, 2025
-
The Prognostic Test Accuracy of the Short and Standard Forms of the Montreal Cognitive Assessment
Part of Cerebrovascular Diseases, p. 308-314, 2025
- DOI for The Prognostic Test Accuracy of the Short and Standard Forms of the Montreal Cognitive Assessment
- Download full text (pdf) of The Prognostic Test Accuracy of the Short and Standard Forms of the Montreal Cognitive Assessment
-
Part of Frontiers in Neurology, 2025
- DOI for Plasma cholinergic markers are associated with post-stroke walking recovery-revisiting the STROKEWALK study
- Download full text (pdf) of Plasma cholinergic markers are associated with post-stroke walking recovery-revisiting the STROKEWALK study
-
Part of Dementia and Geriatric Cognitive Disorders, p. 277-295, 2024
All publications
Articles in journal
-
Part of Upsala Journal of Medical Sciences, 2025
- DOI for Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trial
- Download full text (pdf) of Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trial
-
Part of International Journal of Stroke, p. 540-549, 2025
-
The Prognostic Test Accuracy of the Short and Standard Forms of the Montreal Cognitive Assessment
Part of Cerebrovascular Diseases, p. 308-314, 2025
- DOI for The Prognostic Test Accuracy of the Short and Standard Forms of the Montreal Cognitive Assessment
- Download full text (pdf) of The Prognostic Test Accuracy of the Short and Standard Forms of the Montreal Cognitive Assessment
-
Part of Frontiers in Neurology, 2025
- DOI for Plasma cholinergic markers are associated with post-stroke walking recovery-revisiting the STROKEWALK study
- Download full text (pdf) of Plasma cholinergic markers are associated with post-stroke walking recovery-revisiting the STROKEWALK study
-
Part of BMJ Open, 2024
- DOI for Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden
- Download full text (pdf) of Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden
-
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
Part of Upsala Journal of Medical Sciences, 2024
- DOI for Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
- Download full text (pdf) of Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
-
Part of International Journal of Stroke, p. 798-808, 2024
- DOI for Individual patient data meta-analysis of the effects of fluoxetine on functional outcomes after acute stroke
- Download full text (pdf) of Individual patient data meta-analysis of the effects of fluoxetine on functional outcomes after acute stroke
-
Part of CEREBRAL CIRCULATION-COGNITION AND BEHAVIOR, 2024
- DOI for Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment
- Download full text (pdf) of Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment
-
Part of Lancet Neurology, p. 117-126, 2023
-
Physical Activity Trajectories and Functional Recovery After Acute Stroke Among Adults in Sweden
Part of JAMA Network Open, 2023
- DOI for Physical Activity Trajectories and Functional Recovery After Acute Stroke Among Adults in Sweden
- Download full text (pdf) of Physical Activity Trajectories and Functional Recovery After Acute Stroke Among Adults in Sweden
-
Part of Journal of Rehabilitation Medicine, 2023
- DOI for Development of a Swedish short version of the Montreal Cognitive Assessment for cognitive screening in patients with stroke
- Download full text (pdf) of Development of a Swedish short version of the Montreal Cognitive Assessment for cognitive screening in patients with stroke
-
Part of BMC Geriatrics, 2023
- DOI for The impact of stroke on the ability to live an independent life at old age: a community-based cohort study of Swedish men
- Download full text (pdf) of The impact of stroke on the ability to live an independent life at old age: a community-based cohort study of Swedish men
-
Part of International Journal of Stroke, p. 543-554, 2023
- DOI for Predictors of post-stroke cognitive impairment using acute structural MRI neuroimaging: A systematic review and meta-analysis
- Download full text (pdf) of Predictors of post-stroke cognitive impairment using acute structural MRI neuroimaging: A systematic review and meta-analysis
-
Part of Trials, 2023
- DOI for Study protocol for a randomized, controlled, multicentre, pragmatic trial with Rehabkompassen®-a digital structured follow-up tool for facilitating patient-tailored rehabilitation in persons after stroke
- Download full text (pdf) of Study protocol for a randomized, controlled, multicentre, pragmatic trial with Rehabkompassen®-a digital structured follow-up tool for facilitating patient-tailored rehabilitation in persons after stroke
-
Part of International Journal of Stroke, p. 285-295, 2023
- DOI for Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the EFFECTS trial dataset.
- Download full text (pdf) of Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the EFFECTS trial dataset.
-
Part of Journal of the American Heart Association, 2022
- DOI for Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings
- Download full text (pdf) of Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings
-
Part of JMIR Human Factors, 2022
-
Part of Trials, 2022
- DOI for Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
- Download full text (pdf) of Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
-
Part of Child's Nervous System, p. 1605-1612, 2022
- DOI for Complete functional recovery in a child after endovascular treatment of basilar artery occlusion caused by spontaneous dissection: a case report
- Download full text (pdf) of Complete functional recovery in a child after endovascular treatment of basilar artery occlusion caused by spontaneous dissection: a case report
-
Selective Serotonin Reuptake Inhibitors for Stroke Recovery
Part of Stroke, 2022
-
Levels of physical activity before and after stroke in relation to early cognitive function
Part of Scientific Reports, 2021
- DOI for Levels of physical activity before and after stroke in relation to early cognitive function
- Download full text (pdf) of Levels of physical activity before and after stroke in relation to early cognitive function
-
Part of Clinical Rehabilitation, p. 276-287, 2021
- DOI for Effects on walking performance and lower body strength by short message service guided training after stroke or transient ischemic attack (The STROKEWALK Study): a randomized controlled trial
- Download full text (pdf) of Effects on walking performance and lower body strength by short message service guided training after stroke or transient ischemic attack (The STROKEWALK Study): a randomized controlled trial
-
Part of BMJ Open, 2021
- DOI for Potential effects on cardiometabolic risk factors and body composition by short message service (SMS)-guided training after recent minor stroke or transient ischaemic attack: post hoc analyses of the STROKEWALK randomised controlled trial
- Download full text (pdf) of Potential effects on cardiometabolic risk factors and body composition by short message service (SMS)-guided training after recent minor stroke or transient ischaemic attack: post hoc analyses of the STROKEWALK randomised controlled trial
-
Part of Stroke, p. 2502-2509, 2021
-
Part of Stroke, p. 3082-3087, 2021
- DOI for Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke Results From EFFECTS, a Randomized Controlled Trial
- Download full text (pdf) of Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke Results From EFFECTS, a Randomized Controlled Trial
-
Part of BMJ Open, 2021
- DOI for Development of a short-form Swedish version of the Montreal Cognitive Assessment (s-MoCA-SWE): protocol for a cross-sectional study
- Download full text (pdf) of Development of a short-form Swedish version of the Montreal Cognitive Assessment (s-MoCA-SWE): protocol for a cross-sectional study
-
Stroke survivors' priorities for research related to life after stroke
Part of Topics in Stroke Rehabilitation, p. 153-158, 2021
- DOI for Stroke survivors' priorities for research related to life after stroke
- Download full text (pdf) of Stroke survivors' priorities for research related to life after stroke
-
Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT
Part of Health Technology Assessment, p. 1-94, 2020
- DOI for Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT
- Download full text (pdf) of Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT
-
Part of Lancet Neurology, p. 651-660, 2020
-
Part of Trials, 2020
- DOI for Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
- Download full text (pdf) of Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
-
Part of Trials, 2020
- DOI for Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis
- Download full text (pdf) of Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis
-
Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials
Part of International Journal of Stroke, p. 365-376, 2020
-
Trends in stroke reperfusion treatment and outcomes in New Zealand
Part of Internal medicine journal (Print), p. 1367-1372, 2020
-
Validation of the Simplified Modified Rankin Scale Questionnaire
Part of European Neurology, p. 493-499, 2020
-
Part of Lancet Neurology, p. 661-669, 2020
-
Selective Serotonin Reuptake Inhibitors for Stroke Recovery
Part of Stroke, 2020
-
Part of Trials, 2019
- DOI for Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel
- Download full text (pdf) of Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel
-
TWIST tenecteplase in wake-up ischaemic stroke trial
Part of European Journal of Neurology, 2019
-
Part of European Stroke Journal, p. 307-317, 2019
-
Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial
Part of Stroke, p. 3280-3282, 2019
-
Återinsättning av trombocythämmare RESTART ger oss (nästan) hela svaret
Part of Neurologi i sverige, 2019
-
Part of European Stroke Journal, 2019
-
Hur ska alla i Sverige få tillgång till trombektomi vid stroke?
Part of Neurologi i Sverige, p. 46-49, 2019
-
Part of The Lancet, p. 265-274, 2019
- DOI for Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
- Download full text (pdf) of Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
-
Part of Journal of the American Heart Association, 2018
-
Part of Trials, 2018
-
Trombektomi är möjlig upp till 24 timmar efter stroke: Om man väljer rätt patient
Part of Neurologi i Sverige, p. 50-53, 2018
-
Part of European Stroke Journal, 2018
-
Part of Trials, 2017
-
Part of BMJ Open, 2017
-
Part of Scientific Reports, 2017
-
Part of Stroke, p. 353-360, 2017
- DOI for Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke
- Download full text (pdf) of Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke
-
Part of Journal of Stroke & Cerebrovascular Diseases, p. 2264-2271, 2017
-
Medicinsk behandling av cervical dissektion
Part of Neurologi i Sverige, p. 58-62, 2017
-
Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?
Part of Journal of Thrombosis and Thrombolysis, p. 104-111, 2017
-
Part of Stroke, p. 1256-1261, 2017
-
EFFECTS: en randomiserad kontrollerad studie av fluoxetine efter stroke
Part of Neurologi i Sverige, p. 47-51, 2016
-
Part of Acta Neurochirurgica, p. 233-239, 2016
-
Part of Lancet Neurology, p. 1028-34, 2016
-
Part of Trials, 2015
- DOI for The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.
- Download full text (pdf) of The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.
-
Part of BMJ Open, 2015
-
Part of Lancet Neurology, p. 485-96, 2015
-
Trombektomi vid ischemisk stroke: ett paradigmskifte inom akut strokebehandling
Part of Neurologi i Sverige, p. 14-20, 2015
-
Part of Stroke, p. 1374-1376, 2015
-
Prevalence of spasticity after aneurysmal subarachnoid haemorrhage
Part of Journal of Rehabilitation Medicine, p. 23-27, 2014
-
Part of Lancet Neurology, p. 768-76, 2013
-
Agreement between ambulance nurses and physicians in assessing stroke patients
Part of Acta Neurologica Scandinavica, p. 49-55, 2013
-
Part of Acta Neurochirurgica, p. 587-593, 2013
-
Part of Stroke, 2013
-
Part of Trials, p. 252, 2011
- DOI for Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
- Download full text (pdf) of Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
-
Outcome After Spontaneous Subarachnoid Hemorrhage Measured With the EQ-5D
Part of Stroke, p. 3284-3286, 2011
-
Part of Stroke, p. 319-324, 2010
-
Part of Stroke, 2010
-
International comparisons of stroke costs are always limited
Part of Stroke, 2010
-
International Comparisons of Stroke Costs Are Always Limited
Part of Stroke, 2010
-
Part of Stroke, 2010
-
Time-course and determinants of spasticity during the first six months following first-ever stroke
Part of Journal of Rehabilitation Medicine, p. 296-301, 2010
-
Risk factors for stroke-related pain 1 year after first-ever stroke
Part of European Journal of Neurology, p. 188-193, 2009
-
Prevalence of disabling spasticity 1 year after first-ever stroke
Part of European Journal of Neurology, p. 533-9, 2008
-
Objective assessment of cervical dystonia: a pilot study
Part of Acta Neurologica Scandinavica, p. 248-53, 2005
-
Part of Lakartidningen, p. 678-82, 2004
Articles, review/survey
-
Part of Dementia and Geriatric Cognitive Disorders, p. 277-295, 2024
-
Part of International Journal of Stroke, p. 618-627, 2022
- DOI for Predicting post-stroke cognitive impairment using acute CT neuroimaging: A systematic review and meta-analysis
- Download full text (pdf) of Predicting post-stroke cognitive impairment using acute CT neuroimaging: A systematic review and meta-analysis
-
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
Part of Cochrane Database of Systematic Reviews, 2021
-
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
Part of Cochrane Database of Systematic Reviews, 2019
-
Migrainous Infarction: Aspects on Risk Factors and Therapy
Part of Current Pain and Headache Reports, p. 255-260, 2012
Comprehensive doctoral thesis
Conference papers
-
The Effects Of Fluoxetine On Fracture Risk After Stroke: Further Analyses From The Focus Trial
p. 714-714, 2019
-
Objective assessment in cervical dystonia
Part of Proceedings from ESMAC 13th Annual Meeting of European Society of Movement Analysis of Adult and Children, 2004